Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
NJ BIO — Recent Advances in ADCs
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
Araris Biotech
NJ BIO — Recent Advances in ADCs
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Antibody–Drug Conjugates: Perspectives and Characterization
Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering
How Far We Have Advanced in the Chemotherapy World - IBL America Online Store
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
Antibody–drug conjugates for cancer - The Lancet
Recent advances of antibody drug conjugates for clinical applications - ScienceDirect
The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology
BTG-driven conjugation: Antibodies for medicine
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Chromatographic evaluation of ADC aggregation and hydrophilicity. (a-f)... | Download Scientific Diagram
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Antibody–Drug Conjugates: Perspectives and Characterization
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
